133 related articles for article (PubMed ID: 26484409)
21. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer.
Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M
Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.
Gilliland FD; Hunt WC; Morris DM; Key CR
Cancer; 1997 Feb; 79(3):564-73. PubMed ID: 9028369
[TBL] [Abstract][Full Text] [Related]
23. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
Yan Y; Hu F; Wu W; Ma R; Huang H
Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
[TBL] [Abstract][Full Text] [Related]
24. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
Liu Y; Yuan L; Yang D; Jin Y
Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of variation trends of thyroid cancer treated in Tianjin Cancer Hospital form 1954 to 2009].
Wei SF; Gao M; Qian BY; Li YG; Zhang Y; Chen WY; Zheng XQ; Li XL; Yu Y; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):613-5. PubMed ID: 22325223
[TBL] [Abstract][Full Text] [Related]
26. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
27. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of serum insulin-like growth factor 1 and its significance in thyroid cancer: An observational study.
Hou YL; Chen JJ; Zhang X; Chen H
Medicine (Baltimore); 2021 May; 100(21):e26165. PubMed ID: 34032777
[TBL] [Abstract][Full Text] [Related]
29. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3.
Kaklamani VG; Linos A; Kaklamani E; Markaki I; Mantzoros C
J Clin Oncol; 1999 Mar; 17(3):813-7. PubMed ID: 10071271
[TBL] [Abstract][Full Text] [Related]
30. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
31. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
Bizzarro T; Martini M; Capodimonti S; Straccia P; Lombardi CP; Pontecorvi A; Larocca LM; Rossi ED
Cancer Cytopathol; 2016 Oct; 124(10):699-710. PubMed ID: 27717284
[TBL] [Abstract][Full Text] [Related]
32. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
[TBL] [Abstract][Full Text] [Related]
33. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
34. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
[TBL] [Abstract][Full Text] [Related]
35. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Ceresini G; Corcione L; Michiara M; Sgargi P; Teresi G; Gilli A; Usberti E; Silini E; Ceda GP
Cancer; 2012 Nov; 118(22):5473-80. PubMed ID: 22517468
[TBL] [Abstract][Full Text] [Related]
36. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
37. Thyroid cancer in Greece. A tertiary center experience.
Gkountouvas A; Nikas M; Chatjimarkou F; Thomas D; Georgiadis P; Kaldrimidis P
J BUON; 2010; 15(4):674-8. PubMed ID: 21229628
[TBL] [Abstract][Full Text] [Related]
38. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
[TBL] [Abstract][Full Text] [Related]
39. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
[TBL] [Abstract][Full Text] [Related]
40. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
